Hospital
Jackson Madison County General Hospital
Jackson Madison County General Hospital was paid $46.51M by Medicaid between Jan 2018 and Dec 2024, across 187 billing codes. Its largest line is 99284, emergency room visit (serious) — 33% of everything it billed.
33Billing provider infoJACKSON MADISON COUNTY GENERAL HOSPITAL
JACKSON, TN 38301
JACKSON, TN 38301
33aNPI1093705428assigned 10/26/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$46.51M
24GClaims1,145,435
24DCodes billed187
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Tennessee
Rank by total paid#3 of 71
Median peer was paid$6.96M
This provider vs. median6.7×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official PRESCOTT, TINA controls 17+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 176,582 | $7.69M | |
| 2019 | 210,843 | $8.71M | |
| 2020 | 154,256 | $6.06M | |
| 2021 | 147,850 | $6.34M | |
| 2022 | 161,328 | $6.71M | |
| 2023 | 176,994 | $7.09M | |
| 2024incomplete | 117,582 | $3.91M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 33% | 66,847 | 60,205 | $15.51M |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 24% | 71,078 | 65,376 | $11.16M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 11% | 24,692 | 21,536 | $5.26M |
| 0202U | Oncology (prostate), multianalyte, gene expression profiling | 4.3% | 7,861 | 7,498 | $2.02M |
| G0378 | Hospital observation service, per hour | 2.5% | 5,063 | 4,059 | $1.15M |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | 2.1% | 15,383 | 7,403 | $990K |
| 42820 | Tonsillectomy and adenoidectomy; younger than age 12 | 1.7% | 519 | 510 | $808K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.6% | 169,482 | 134,749 | $766K |
| 69436 | Tympanostomy (requiring insertion of ventilating tube), general anesthesia | 1.5% | 560 | 543 | $699K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | 1.3% | 1,407 | 1,238 | $583K |
| 77412 | 1.1% | 16,213 | 1,337 | $524K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | 1.1% | 1,875 | 1,181 | $515K |
175 more codes
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | <1% | 12,613 | $458K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 4,110 | $442K |
| A0428 | Ambulance service, basic life support, non-emergency transport, (bls) | <1% | 8,964 | $441K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 2,708 | $307K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 18,610 | $266K |
| A0425 | Ground mileage, per statute mile | <1% | 7,855 | $250K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 90,498 | $247K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 13,625 | $227K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 14,753 | $222K |
| 36415 | Collection of venous blood by venipuncture | <1% | 151,485 | $190K |
| 77336 | <1% | 6,082 | $172K | |
| 77334 | <1% | 1,686 | $169K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 24,513 | $163K |
| 62323 | <1% | 578 | $152K | |
| 84484 | <1% | 11,288 | $150K | |
| 80053 | Comprehensive metabolic panel | <1% | 59,352 | $139K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 31,556 | $134K |
| 36591 | <1% | 3,648 | $113K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 2,503 | $112K |
| 71045 | Radiologic examination, chest; single view | <1% | 40,219 | $109K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | <1% | 204 | $106K |
| 64493 | <1% | 394 | $106K | |
| 41899 | Unlisted procedure, dentoalveolar structures | <1% | 220 | $105K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 11,242 | $98K |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 1,199 | $96K |
| T2005 | Non-emergency transportation; stretcher van | <1% | 2,173 | $89K |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 293 | $74K |
| 97597 | <1% | 3,845 | $67K | |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | <1% | 1,630 | $66K |
| 81025 | <1% | 19,516 | $63K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 2,236 | $63K |
| 77387 | <1% | 8,577 | $57K | |
| 80076 | <1% | 19,525 | $56K | |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 537 | $56K |
| 81001 | <1% | 63,512 | $55K | |
| 77290 | <1% | 707 | $49K | |
| 83690 | <1% | 8,644 | $44K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 2,687 | $42K |
| 77300 | <1% | 516 | $38K | |
| 82728 | <1% | 8,018 | $36K | |
| 77295 | <1% | 109 | $34K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 1,431 | $34K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 616 | $33K |
| J2469 | Injection, palonosetron hcl, 25 mcg | <1% | 852 | $31K |
| 64494 | <1% | 543 | $29K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,906 | $28K |
| 83550 | <1% | 7,956 | $24K | |
| 96417 | <1% | 579 | $24K | |
| 83605 | <1% | 3,387 | $24K | |
| 86850 | <1% | 950 | $20K | |
| T2049 | Non-emergency transportation; stretcher van, mileage; per mile | <1% | 1,998 | $19K |
| 43248 | <1% | 81 | $18K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 1,131 | $18K |
| 83540 | <1% | 7,974 | $17K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 567 | $17K |
| G0260 | Injection procedure for sacroiliac joint; provision of anesthetic, steroid and/or other therapeutic agent, with or without arthrography | <1% | 59 | $15K |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 931 | $15K |
| 82607 | <1% | 3,106 | $15K | |
| 86900 | <1% | 986 | $15K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 2,536 | $14K |
| 87430 | <1% | 2,744 | $12K | |
| 96367 | <1% | 729 | $12K | |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 2,693 | $11K |
| A0380 | Bls mileage (per mile) | <1% | 1,389 | $11K |
| 83735 | <1% | 3,351 | $10K | |
| 85045 | <1% | 7,239 | $10K | |
| 87807 | <1% | 1,440 | $10K | |
| 86140 | <1% | 3,468 | $10K | |
| 86901 | <1% | 996 | $8K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 47 | $8K |
| 99213 | Doctor's office visit, returning patient (routine) | <1% | 506 | $8K |
| 82150 | <1% | 1,343 | $8K | |
| 87631 | <1% | 113 | $8K | |
| C1713 | Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) | <1% | 18 | $7K |
| 77280 | <1% | 188 | $6K | |
| 93458 | <1% | 16 | $6K | |
| 82746 | <1% | 1,945 | $6K | |
| 87040 | <1% | 598 | $5K | |
| 82962 | <1% | 2,474 | $4K | |
| 82652 | <1% | 215 | $4K | |
| 82533 | <1% | 1,252 | $4K | |
| J1756 | Injection, iron sucrose, 1 mg | <1% | 215 | $4K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 25 | $4K |
| 11043 | <1% | 70 | $4K | |
| 83880 | <1% | 556 | $4K | |
| 11045 | <1% | 436 | $4K | |
| 87581 | <1% | 113 | $3K | |
| 87486 | <1% | 113 | $3K | |
| 87798 | Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism | <1% | 113 | $3K |
| 86334 | <1% | 673 | $3K | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 187 | $3K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 184 | $3K |
| 96523 | <1% | 175 | $3K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 211 | $2K |
| 93925 | <1% | 72 | $2K | |
| 80061 | Lipid panel | <1% | 478 | $2K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 176 | $2K |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 160 | $2K |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 175 | $2K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 29 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 264 | $2K |
| 74018 | <1% | 242 | $2K | |
| 77014 | <1% | 89 | $2K | |
| 85610 | <1% | 1,093 | $1K | |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 27 | $1K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 204 | $1K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 287 | $1K |
| 83615 | <1% | 1,126 | $1K | |
| 82378 | <1% | 388 | $1K | |
| 87205 | <1% | 800 | $1K | |
| 87081 | <1% | 336 | $1K | |
| 76801 | <1% | 15 | $996.97 | |
| 96415 | <1% | 42 | $853.51 | |
| 20610 | <1% | 35 | $843.19 | |
| 85730 | <1% | 405 | $828.42 | |
| L8699 | Prosthetic implant, not otherwise specified | <1% | 543 | $724.41 |
| 84702 | <1% | 41 | $720.16 | |
| 80306 | <1% | 97 | $716.65 | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 37 | $693.00 |
| 84100 | <1% | 395 | $635.66 | |
| 87070 | <1% | 800 | $618.83 | |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 14 | $616.28 |
| 93010 | Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only | <1% | 118 | $564.68 |
| 85018 | <1% | 303 | $545.28 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 29 | $504.34 |
| 85379 | <1% | 55 | $423.48 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 70 | $411.84 |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 15 | $402.36 |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 27 | $400.68 |
| 87077 | <1% | 402 | $399.43 | |
| 85652 | <1% | 452 | $398.02 | |
| 81003 | <1% | 660 | $376.65 | |
| 99152 | <1% | 3,307 | $357.19 | |
| 85660 | <1% | 38 | $324.94 | |
| 84439 | <1% | 76 | $316.10 | |
| 84134 | <1% | 293 | $308.46 | |
| 82565 | <1% | 178 | $298.12 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 437 | $294.26 |
| 88300 | <1% | 934 | $284.91 | |
| 84630 | <1% | 285 | $248.53 | |
| 83883 | <1% | 53 | $245.72 | |
| 83874 | <1% | 27 | $231.32 | |
| 94150 | <1% | 12 | $230.62 | |
| 87186 | <1% | 232 | $212.76 | |
| 82465 | <1% | 118 | $201.90 | |
| 86300 | <1% | 62 | $172.30 | |
| 84145 | <1% | 14 | $171.95 | |
| 84520 | <1% | 98 | $137.43 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 3,360 | $133.81 |
| 87210 | <1% | 28 | $114.52 | |
| 87400 | <1% | 32 | $98.01 | |
| 88142 | <1% | 12 | $89.40 | |
| 85027 | <1% | 77 | $85.51 | |
| G0008 | Administration of influenza virus vaccine | <1% | 15 | $79.91 |
| 72100 | <1% | 13 | $58.30 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 774 | $48.88 |
| 82040 | <1% | 130 | $43.14 | |
| 88342 | <1% | 1,009 | $40.38 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 119 | $28.00 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 25 | $17.51 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 16 | $6.00 |
| V2632 | Posterior chamber intraocular lens | 0% | 1,794 | $0.00 |
| A9270 | Non-covered item or service | 0% | 263 | $0.00 |
| 99153 | Mod sedat endo service >5yrs | 0% | 686 | $0.00 |
| J3490 | Unclassified drugs | 0% | 33 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 276 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 17 | $0.00 |
| C1725 | Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) | 0% | 25 | $0.00 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 0% | 31 | $0.00 |
| C1750 | Catheter, hemodialysis/peritoneal, long-term | 0% | 14 | $0.00 |
| 64495 | 0% | 14 | $0.00 | |
| 77002 | 0% | 35 | $0.00 | |
| 76942 | 0% | 38 | $0.00 | |
| C1780 | Lens, intraocular (new technology) | 0% | 87 | $0.00 |
| J7030 | Infusion, normal saline solution , 1000 cc | 0% | 13 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialPRESCOTT, TINA (PRESIDENT AND CEO)
| Provider | Location | Paid |
|---|---|---|
| Pathways of Tennessee, INC. | Jackson, TN | $30.54M |
| Dyersburg Health | Dyersburg, TN | $13.19M |
| Jackson-Madison County General Hospital | Jackson, TN | $12.97M |
| Jackson-Madison County General Hospital | Jackson, TN | $7.37M |
| WT Medical Associates | Dyersburg, TN | $5.52M |
| West Tennessee Healthcare Henry County | Paris, TN | $4.47M |
| Therapy & Learning Center INC | Jackson, TN | $4.19M |
| Martin Health | Martin, TN | $3.94M |
| Milan General Hospital, INC. | Milan, TN | $3.54M |
| Camden General Hospital, INC. | Camden, TN | $3.46M |
| Pathways of Tennessee, INC. | Jackson, TN | $3.30M |
| Bolivar General Hospital, INC. | Bolivar, TN | $2.36M |
| Martin Health | South Fulton, TN | $1.47M |
| Lift Therapy, INC. | Jackson, TN | $778K |
| Jackson-Madison County General Hospital | Jackson, TN | $449K |
| West Tennessee Healthcare Henry County | Paris, TN | $136K |
| Jackson-Madison County General Hospital | Jackson, TN | $108K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.